Bachelor of Health Science (BHS) Degree Practice Exam 2025 - Free BHS Practice Questions and Study Guide

The vaccine that was licensed in 2006 to prevent cervical cancer is the human papillomavirus (HPV) vaccine. This vaccine works by providing immunity against the types of HPV that are most commonly associated with cervical cancer, particularly HPV types 16 and 18. These two strains are responsible for the majority of cervical cancer cases. By vaccinating individuals before they become sexually active, the HPV vaccine significantly reduces the risk of developing not only cervical cancer but also other cancers linked to HPV, such as anal and oropharyngeal cancers.

The other options listed are primarily vaccines for different diseases. Hepatitis B vaccine protects against hepatitis B virus infection, which has its own health implications but does not specifically target cervical cancer. The influenza vaccine is designed to prevent influenza virus infections and does not involve HPV at all. The measles vaccine protects against measles virus and has no connection to cervical cancer prevention. Thus, the focus on the HPV vaccine in the context of cervical cancer makes it the correct choice.